<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://per.alphagenics.co/blog/per-cremas-ghk-cu-peru-digemid-nso-evidencia/</loc><news:news><news:publication><news:name>Alphagenics Perú</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-08</news:publication_date><news:title>Cremas con GHK-Cu en Perú: evidencia y exigencias de la Digemid</news:title></news:news></url><url><loc>https://per.alphagenics.co/blog/per-ley-31014-mesa-tecnica-congreso-colegio-medico-sustancias-modelantes/</loc><news:news><news:publication><news:name>Alphagenics Perú</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Ley 31014 en Perú: el Congreso reabre las sustancias modelantes</news:title></news:news></url><url><loc>https://per.alphagenics.co/blog/per-nad-digemid-alertas-evidencia-humanos/</loc><news:news><news:publication><news:name>Alphagenics Perú</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-08</news:publication_date><news:title>NAD+ en Perú: la Digemid alertó dos veces y la evidencia sigue corta</news:title></news:news></url><url><loc>https://per.alphagenics.co/blog/per-serum-botox-sin-nso-digemid-alerta-123-2026/</loc><news:news><news:publication><news:name>Alphagenics Perú</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-08</news:publication_date><news:title>«Sérum bótox» sin NSO en Perú: Alerta Digemid 123-2026</news:title></news:news></url></urlset>
